Does Intrathecal Morphine Affect Outcomes in Spine Deformity Surgery

NCT ID: NCT05092828

Last Updated: 2022-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-01

Study Completion Date

2023-12-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare the effects of intrathecal morphine to traditional pain management strategies on post-operative recovery for deformity surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background Deformity surgery is considered one of the most painful procedures patients can undergo in medicine today. Stringent protocols for pain management have done much to dramatically increase patient satisfaction, but the procedure still lags considerably behind advances in pain control when compared to other procedures such as total joint surgery. Specifically, it has been reported that over half of patients undergoing spine surgery report inadequate pain control the first 24 hours after surgery. Uncontrolled pain has been shown to correlate with prolonged hospital stays, delayed ambulation, poor functional outcomes, and increased risk for the development of chronic pain. Furthermore, the large amount of narcotics given to patients in an attempt to mitigate their pain postoperatively often leads to significant complications in their own right, such as ileus, mental status changes, and nausea. New modalities to treat postoperative pain, especially in the initial days following deformity correction, are needed.

Intrathecal (subarachnoid) injection of morphine has been used to treat severe pain since the 1970's. Its efficacy in treating postoperative pain has been well documented in various specialties including obstetrics, oncology, general surgery, and orthopedic surgery. Specific to spine surgery, intrathecal morphine is an attractive option given the access and visualization of the thecal sac in addition to the high demand of pain control required postoperatively. However, there remains no definitive consensus regarding the use of intrathecal morphine in spine surgery. Current literature is limited by few randomized trials, small sample sizes, heterogeneity of outcomes recorded, and an unclear association with complications. Additionally, there is a paucity of data dedicated to patients undergoing deformity correction. Accordingly, there is a need for high-quality trials to investigate the role of intrathecal morphine in adult spinal deformity surgery.

In this study, we hypothesized that the use of intrathecal morphine will significantly reduce post-operative pain after deformity surgery, reduce opioid utilization, decrease hospital stay, allow for earlier ambulation, increase patient satisfaction, and have comparable complications to traditional pain management strategies. This study aims to compare the effects of intrathecal morphine to traditional pain management strategies on post-operative recovery for deformity surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Nursing staff and physical therapists will be blinded to intrathecal morphine utilization as to not bias the input of these variables

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study Group

Patients in this group will receive intrathecal morphine in addition to standard post-operative pain medications

Group Type ACTIVE_COMPARATOR

Intrathecal Morphine Injection

Intervention Type DRUG

In addition to standard post-operative pain management, Intratechal morphine will be given to patients in this group.

Control Group

Patients in this group will receive standard post-operative pain medications but will not receive intrathecal morphine

Group Type ACTIVE_COMPARATOR

Pain Relieving

Intervention Type DRUG

Patient in this group will receive standard postoperative pain medications other than inthrathecal injection of morphine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intrathecal Morphine Injection

In addition to standard post-operative pain management, Intratechal morphine will be given to patients in this group.

Intervention Type DRUG

Pain Relieving

Patient in this group will receive standard postoperative pain medications other than inthrathecal injection of morphine

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Subarachnoid injection of morphine Standard Post-operative pain medications other than intrathecal morphine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients 18 years and older with a diagnosis of adult or degenerative scoliosis,
* Patients meeting criteria for surgical correction involving back and/or leg pain
* Fusion of 4+ levels,
* Competency to undergo informed consent process,
* Medical clearance for spinal fusion surgery,

Exclusion Criteria

* Patients with lumbar spine inaccessible for intrathecal Duragesic (fused L2-S1)
* Patients undergoing 3 or less levels of fusion
* Patients with neuromuscular disease
* Opioid intolerance or dependence
* Severe coexisting diseases
* ASA III
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sonoran Spine Research and Education Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Chang, MD

Clinical Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael S Chang, MD

Role: PRINCIPAL_INVESTIGATOR

Sonoran Spine Research and Education Foundation

Andrew Chung, DO

Role: PRINCIPAL_INVESTIGATOR

Sonoran Spine Research and Education Foundation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sonoran Spine in Collaboration with HonorHealth

Tempe, Arizona, United States

Site Status RECRUITING

Sonoran Spine

Tempe, Arizona, United States

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Biodun Adeniyi, MBBS, MS

Role: CONTACT

4805973138

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Biodun A Adeniyi, MBBS, MS

Role: primary

623-683-8123

Biodun Adeniyi, MBBS, MS

Role: primary

480-597-3138

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SS-MSC-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Methadone and Ketamine for Spinal Surgery
NCT02827526 COMPLETED PHASE4